2-106413270-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001144013.2(RGPD3):āc.5080A>Gā(p.Ile1694Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,611,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD3 | NM_001144013.2 | c.5080A>G | p.Ile1694Val | missense_variant | 22/23 | ENST00000409886.4 | NP_001137485.1 | |
RGPD3 | XM_017004738.2 | c.5104A>G | p.Ile1702Val | missense_variant | 23/24 | XP_016860227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD3 | ENST00000409886.4 | c.5080A>G | p.Ile1694Val | missense_variant | 22/23 | 1 | NM_001144013.2 | ENSP00000386588 | P2 | |
RGPD3 | ENST00000304514.11 | c.5062A>G | p.Ile1688Val | missense_variant | 22/23 | 2 | ENSP00000303659 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 29
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459680Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726148
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.5080A>G (p.I1694V) alteration is located in exon 22 (coding exon 22) of the RGPD3 gene. This alteration results from a A to G substitution at nucleotide position 5080, causing the isoleucine (I) at amino acid position 1694 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at